ES2086464T3 - Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos. - Google Patents

Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.

Info

Publication number
ES2086464T3
ES2086464T3 ES91120914T ES91120914T ES2086464T3 ES 2086464 T3 ES2086464 T3 ES 2086464T3 ES 91120914 T ES91120914 T ES 91120914T ES 91120914 T ES91120914 T ES 91120914T ES 2086464 T3 ES2086464 T3 ES 2086464T3
Authority
ES
Spain
Prior art keywords
compounds
group
well
elevated
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120914T
Other languages
English (en)
Inventor
Hermann Krahling
Samuel David
Insa Dr Hell
Ulf Preuschoff
Ivan Ban
Marie-Odile Christen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Application granted granted Critical
Publication of ES2086464T3 publication Critical patent/ES2086464T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/42—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having etherified hydroxy groups and at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Noodles (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE DESCRIBEN COMPUESTOS ACTIVOS Y FARMACOLOGICOS, ASI COMO SUS SALES, DE LA FORMULA GENERAL I DONDE N REPRESENTA 2-5, M REPRESENTA 2-6, R ELEVADO 1 SIGNIFICA HIDROGENO O ALQUILO BAJO, R (AL CUADRADO) REPRESENTA UN GRUPO DE OR ELEVADO 4, DONDE R ELEVADO 5 SIGNIFICA ALQUILO BAJO 0, DADO EL CASO Y DENTRO DE UN ANILLO DE FENILO, UN GRUPO DE FENILO SUSTITUIDO O GRUPOS DE BAJOALQUILO DE FENILO, O R ELEVADO 2 REPRESENTA (INCOMPRENSIBLE) DONDE R ELEVADO 5 Y R ELEVADO 6, INDEPENDIENTEMENTE ENTRE SI SIGNIFICAN CADA UNO HIDROGENO, ALQUILO BAJO O, DADO EL CASO Y DENTRO DE UN ANILLO DE FENILO UN GRUPO SUSTITUIDO DE FENILO O UN GRUPO DE BAJOALQUILO DE FENILO O R ELEVADO 5 Y R ELEVADO 6 REPRESENTA, JUNTO CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS, UN HETEROCICLO SATURADO DE 5 O 6 MIEMBROS, R ELEVADO 3 REPRESENTA UN RESTO DE HIDROGENO DE CARBONO DERIVADO DE TERPENOS MONO O BICICLICOS SATURADOS, CON 10 U 11 ATOMOS DE CARBONO Y Z SIGNIFICA OXIGENO. EN CASO DE QUE R ELEVADO 3 SIGNIFIQUE UN RESTO DE DIHIDRONOPIL, TAMBIEN SIGNIFICA AZUFRE.
ES91120914T 1990-12-19 1991-12-05 Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos. Expired - Lifetime ES2086464T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4040633 1990-12-19
DE4130947 1991-09-18

Publications (1)

Publication Number Publication Date
ES2086464T3 true ES2086464T3 (es) 1996-07-01

Family

ID=25899499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120914T Expired - Lifetime ES2086464T3 (es) 1990-12-19 1991-12-05 Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.

Country Status (21)

Country Link
US (1) US5212173A (es)
EP (1) EP0491243B1 (es)
JP (1) JPH04308557A (es)
KR (1) KR920012009A (es)
CN (1) CN1062526A (es)
AT (1) ATE138061T1 (es)
CA (1) CA2057990A1 (es)
CS (1) CS387491A3 (es)
DE (2) DE59107813D1 (es)
DK (1) DK0491243T3 (es)
ES (1) ES2086464T3 (es)
FI (1) FI915980L (es)
GR (1) GR3019921T3 (es)
HU (1) HUT61967A (es)
IE (1) IE914298A1 (es)
IL (1) IL100286A (es)
MX (1) MX9102666A (es)
NO (1) NO177494C (es)
NZ (1) NZ241001A (es)
PT (1) PT99851A (es)
TW (1) TW203046B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019219994A1 (es) * 2018-05-14 2019-11-21 Tampocal, Sl Máquina de tampografía para piezas de calzado y procedimiento de funcionamiento de la misma

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298483A (en) 1992-03-30 1994-03-29 Tropicana Products, Inc. New matter of composition and method for using the same as plant bioregulators
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
GB9321812D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Plc Pharmaceuticals
US5710099A (en) * 1996-02-27 1998-01-20 The United States Of America As Represented By The Secretary Of Agriculture Bioactive compounds
US11739050B2 (en) * 2021-09-07 2023-08-29 Sci Pharmtech Inc. Method for purification of terpenoid amino alcohol derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019219994A1 (es) * 2018-05-14 2019-11-21 Tampocal, Sl Máquina de tampografía para piezas de calzado y procedimiento de funcionamiento de la misma

Also Published As

Publication number Publication date
NO177494C (no) 1995-09-27
DK0491243T3 (da) 1996-06-10
AU642322B2 (en) 1993-10-14
IE914298A1 (en) 1992-07-01
NZ241001A (en) 1994-11-25
CA2057990A1 (en) 1992-06-20
FI915980A7 (fi) 1992-06-20
US5212173A (en) 1993-05-18
DE4140174A1 (de) 1992-07-02
ATE138061T1 (de) 1996-06-15
EP0491243A1 (de) 1992-06-24
KR920012009A (ko) 1992-07-25
EP0491243B1 (de) 1996-05-15
TW203046B (es) 1993-04-01
IL100286A0 (en) 1992-09-06
IL100286A (en) 1996-05-14
GR3019921T3 (en) 1996-08-31
NO915011D0 (no) 1991-12-18
FI915980A0 (fi) 1991-12-18
MX9102666A (es) 1992-06-01
PT99851A (pt) 1992-12-31
CS387491A3 (en) 1992-07-15
AU8982891A (en) 1992-06-25
JPH04308557A (ja) 1992-10-30
NO177494B (no) 1995-06-19
NO915011L (no) 1992-06-22
HU913892D0 (en) 1992-02-28
DE59107813D1 (de) 1996-06-20
FI915980L (fi) 1992-06-20
CN1062526A (zh) 1992-07-08
HUT61967A (en) 1993-03-29

Similar Documents

Publication Publication Date Title
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
GT199900119A (es) Jarabe antihistaminico estabilizado.
ES475240A1 (es) Un procedimiento de compuestos polienicos.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES8305761A1 (es) Un procediemiento para la preparacion de lactamas biciclicas.
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
FI902872A0 (fi) Anvaendningen av loesliga pyrofosfatsalter foer framstaellning av munvaordskompositioner.
AR209755A1 (es) Nuevos compuestos derivados de la 2-hidroxi-c1-4-alquil sustituido benzofenoxima,utiles como productos intermediarios,que son terapeuticamente inactivos y particularmente apropiados para la preparacion de los correspondientes derivados benzisoxozolicos biologicamente activos
ES8308841A1 (es) "un procedimiento para la preparacion de derivados tetrassubstitudos del benceno".
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
DK208186A (da) P-sulfofenylalkylkarbonater samt detergentblandinger og detergentadditiver indeholdende saadanne forbindelser
ES2126581T3 (es) Derivados de 3-(piperazino-alquil)indol condensados en posiciones 1,7, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
ES2086464T3 (es) Compuestos de alquilaminoalquil-amina y -eter, asi como procedimientos y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
ES2000502A6 (es) Un procedimiento para la preparacion de poli-4-aminopirrol-2-carboxamido derivados
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
ES2196614T3 (es) Analogos de la 1-3-dihidroxi-20,20-dialquil-vitamina d3.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES8405783A1 (es) Procedimiento para la obtencion de derivados de n-oxidos de la piridina.
MX168931B (es) Procedimiento para preparar compuestos de organofosforo
ES2063465T3 (es) Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8103580L (sv) N?726-substituerade adenosiner
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES2090219T3 (es) Compuestos de fenilalquilaminoalquilo asi como procedimientos para su preparacion y medicamentos que contienen a estos compuestos.
ES447732A1 (es) Procedimiento para la preparacion de autraquinon-bis-amidi- nas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 491243

Country of ref document: ES